SYNACTHENE 0.25 mg/1 ml, solution for injection ampoule, 1 ml
Active ingredients: TÉTRACOSACTIDE
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Solution for injectionampoule, 1 mlintramusculaire;intraveineuse
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- SYNACTHENE 0,25 mg/1 ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 ampoule(s) en verre de 1 ml
- Marketing authorisation holder
- ALFASIGMA (ITALIE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Apr 1980
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64606555CIP73182869CIP133400931828693Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TÉTRACOSACTIDEsolution | 0,25 mg · 1 ml de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.